Other
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified: > Other: > Other > Other
Duty Rate (from China)
Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Products classified under HTS 3002.90.52.50
Human Serum Albumin USP 25% Solution
A sterile solution of human serum albumin at 25% concentration, prepared from human plasma for therapeutic use in treating hypovolemia and shock. It falls under HTS 3002.90.52.50 as a blood fraction prepared for therapeutic use, derived from human blood through fractionation processes. This immunological product supports plasma volume expansion in clinical settings.
IVIG Intravenous Immunoglobulin 10% Infusion
A pooled immunoglobulin G preparation from human plasma, used therapeutically for primary immunodeficiency and autoimmune disorders. Classified under HTS 3002.90.52.50 as an immunological product and blood fraction obtained via biotechnological purification. It modulates immune responses in patients with antibody deficiencies.
Monoclonal Antibody Infliximab Biosimilar
A recombinant chimeric monoclonal antibody targeting TNF-alpha, used for treating inflammatory conditions like rheumatoid arthritis. It qualifies under HTS 3002.90.52.50 as an immunological product directly involved in immune regulation, produced via biotechnological processes. Administered intravenously for therapeutic purposes.
Interferon Beta-1a Injection for MS
A recombinant interferon beta-1a formulation for relapsing multiple sclerosis treatment, regulating immune processes. Falls under HTS 3002.90.52.50 as an immunological product (interferon) prepared for therapeutic use via biotechnological methods. It reduces disease activity in neurological conditions.
Recombinant Human Erythropoietin Alfa
A biotechnologically produced hematopoietin stimulating red blood cell production, used in anemia treatment for chronic kidney disease patients. Classified in HTS 3002.90.52.50 as an immunological product (hematopoietin) for therapeutic use. It is a growth factor directly involved in blood cell regulation.
Anti-Hemophilic Factor VIII Concentrate
A plasma-derived or recombinant Factor VIII concentrate for preventing bleeding in hemophilia A patients. It is a blood fraction and immunological product under HTS 3002.90.52.50, prepared for therapeutic prophylactic use. Essential for clotting factor replacement therapy.
Botulinum Toxin Type A for Therapeutic Use
Purified botulinum toxin type A complex, indicated for cervical dystonia and spasticity management. Falls under HTS 3002.90.52.50 as a toxin prepared for therapeutic use, a culture-derived product modulating neuromuscular transmission. Used in measured doses for neurological conditions.
Human Normal Immunoglobulin for IV Use
A sterile immunoglobulin preparation from normal human plasma donors, for replacement therapy in immunodeficiencies. HTS 3002.90.52.50 covers it as other blood fractions and immunological products for therapeutic use. Provides passive immunity support.
Pegylated Interferon Alfa-2a
Pegylated recombinant interferon alfa-2a for chronic hepatitis C treatment, extending half-life for weekly dosing. An immunological product under HTS 3002.90.52.50 for therapeutic immune modulation. Biotechnologically modified cytokine.
Tumor Necrosis Factor Receptor Fusion Protein
Soluble TNF receptor fused to immunoglobulin Fc, blocking inflammation in rheumatoid arthritis. HTS 3002.90.52.50 as TNF immunological product via biotech. Therapeutic protein for autoimmune disease.
Interleukin-2 Recombinant for Cancer
Aldesleukin, recombinant IL-2 for metastatic renal cell carcinoma immunotherapy. Immunological chemokine under 3002.90.52.50.
Blood Plasma Protein Fraction 5%
Sterile 5% solution of plasma proteins excluding albumin, for volume expansion. Other blood fraction HTS 3002.90.52.50.
Filgrastim G-CSF Biosimilar
Recombinant granulocyte colony stimulating factor for neutropenia post-chemotherapy. Hematopoietin HTS 3002.90.52.50.
Clotting Factor IX Complex
Virus-inactivated Factor IX complex for hemophilia B prophylaxis. Blood fraction 3002.90.52.50.
Etanercept TNF Inhibitor
Recombinant TNF receptor fusion protein for psoriasis and arthritis. Immunological product 3002.90.52.50.